Tadalafil/TT-701

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameTadalafil/TT-701
Drug Alias NameTT-701/TadalafilLY-2452473/TadalafilTT-701 and TadalafilLY-2452473 and TadalafilTadalafil/LY-2452473 +[7] 
ClassificationSmall molecules
Mechanisms of ActionAndrogen Receptor modulatorsPhosphodiesterase 5A inhibitors
TargetsAndrogen ReceptorPhosphodiesterase 5A
Therapy Area/IndicationsErectile Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes TT-701Tadalafil
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsErectile Dysfunction

Other Information

ATC CodeN/A
Related LinksN/A